Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model
Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...
Huvudupphovsmän: | Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Frontiers Media S.A.
2022-09-01
|
Serie: | Frontiers in Aging Neuroscience |
Ämnen: | |
Länkar: | https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full |
Liknande verk
Liknande verk
-
Urolithin A and nicotinamide riboside differentially regulate innate immune defenses and metabolism in human microglial cells
av: Helena Borland Madsen, et al.
Publicerad: (2024-11-01) -
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner
av: Alejandro Marmolejo-Garza, et al.
Publicerad: (2024-10-01) -
Roles of Nicotinamide Adenine Dinucleotide (NAD+) in Biological Systems
av: Palmiro Poltronieri, et al.
Publicerad: (2018-01-01) -
Enzymatic synthesis of high-titer nicotinamide mononucleotide with a new nicotinamide riboside kinase and an efficient ATP regeneration system
av: Xiao-Long Qian, et al.
Publicerad: (2022-03-01) -
Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
av: Angelique Cercillieux, et al.
Publicerad: (2022-12-01)